SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
First Aid Basics
Start Test
Study First
Subjects
:
health-sciences
,
first-aid
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. 32%/13% male
BRCA1 gene
WT1 gene
Primary tumors that met to brain
prostate cancer incidence/mortality
2. Leukemia - lymphoma
Free radical eliminators
blood cell malignant tumors
Autoimmune (Hashimoto's - myasthenia gravis)
bone malignant tumor
3. Papillary (thyroid) - Serous (ovary) - Meningioma - Mesothelioma
asbestos target
Where you see Psammoma bodies
c - myc gene
smooth muscle benign tumor
4. Malignant melanoma
dysplastic nevus
benign >1 cell type tumor
paraneoplastic effects of small cell lung carcinoma
vinyl chloride target
5. Visceral malignancy (stomach - lung - breast - uterus)
acanthosis nigricans (hyperpig and epidermal thickening)
N- myc gene
Primary tumors that met to liver
primary amyloidosis
6. Blood (leukemia)
Leukocyte extravasation: rolling
Alkylating agents target
acanthosis nigricans (hyperpig and epidermal thickening)
CA-19-9
7. PECAM-1
paraneoplastic effects of leukemias and lymphomas
c - kit gene
Leukocyte extravasation: diapedesis
secondary amyloidosis (reactive systemic)
8. Sarcoma - papillary thyroid cancer
L- myc gene
nitrosamines (smoked foods) target
radiation exposure
blood vessels benign tumor
9. Malignant lymphoma
asbestos target
CEA
skeletal muscle malignant tumor
immunodeficiency states
10. Leiomyosarcoma
benign >1 cell type tumor
smooth muscle malignant tumor
L- myc gene
alpha - fetoprotein
11. Antibodies to presynaptic Ca2+ channels at NM junction
c - kit gene
erb - B2 gene
paraneoplastic effects of thymoma - small cell lung carcinoma
acanthosis nigricans (hyperpig and epidermal thickening)
12. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets
Primary tumors that met to bone
bone malignant tumor
L- myc gene
Primary tumors that met to brain
13. MEN type II and III tyrosine kinase (oncogene)
ret gene
bcl -2 gene
fat benign tumor
Free radical eliminators
14. Tumor marker: melanoma - neural tumors - astrocytomas
S-100
Alkylating agents target
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
Where you see Psammoma bodies
15. Neutrophils (eos in the gut) - plus other granular leukocytes and antibodies.
c - kit gene
ras gene
DPC gene
Acute inflammatory mediators
16. Aggressive malignant lymphomas (non - Hodgkin's) and Kaposi's sarcoma
AIDS
Free radical cell damage
erb - B2 gene
skeletal muscle malignant tumor
17. Erythropoietin
Leukocyte extravasation: rolling
Primary tumors that met to brain
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
malignant mesenchyme tumor (general)
18. Hyperplasia - metaplasia - dysplasia
Neoplasm associated with actinic keratosis
Neoplasm associated with Down Syndrome
Barrett's esophagus (chronic GI reflux)
Reversible - plasias
19. CML tyrosine kinase (oncogene)
smooth muscle benign tumor
Leukocyte extravasation: tight binding
abl gene
skeletal muscle benign tumor
20. Liposarcoma
fat malignant tumor
Resolution of inflammation
Primary tumors that met to bone
Colon and rectal cancer incidence
21. Rhabdomyosarcoma
aflatoxin target
dysplastic nevus
skeletal muscle malignant tumor
CA-19-9
22. GIST cytokine receptor (oncogene)
extrinsic apoptosis
CA-125
NF2 gene
c - kit gene
23. Squamous cell carcinoma of skin
Red (hemorrhagic) infarcts
aflatoxin target
nitrosamines (smoked foods) target
Neoplasm associated with actinic keratosis
24. Sarcoma
benign epithelial tumor
fat benign tumor
breast cancer incidence/mortality
malignant mesenchyme tumor (general)
25. Skin (SqCC) - liver (angiosarcoma)
AIDS
Rb gene
CA-125
arsenic target
26. Esophagus - stomach
Neoplasm associated with actinic keratosis
S-100
nitrosamines (smoked foods) target
calcitonin
27. Hepatocellular carcinoma
cirrosis (alcohol - hepB or C)
bone benign tumor
DPC gene
Neoplasm associated with xeroderma pigmentosum (albinism)
28. Sickle cell (altered shape) - polycythemia (too many) - CHF (unknown)
acanthosis nigricans (hyperpig and epidermal thickening)
Primary tumors that met to bone
causes of decreased ESR
Autoimmune (Hashimoto's - myasthenia gravis)
29. Hemangioma
secondary amyloidosis (reactive systemic)
blood vessels benign tumor
c - kit gene
abl gene
30. PTH- related peptide - TGF- beta - TNF - IL-1
smooth muscle benign tumor
DCC gene
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
skeletal muscle benign tumor
31. ACTH or ACTH- like peptide
N- myc gene
paraneoplastic effects of small cell lung carcinoma
prostate cancer incidence/mortality
beta - hCG
32. Infections - inflammation - cancer - pregnancy - SLE
nitrosamines (smoked foods) target
causes of increased ESR
Leukocyte extravasation: diapedesis
Primary tumors that met to brain
33. Tumor marker: ovarian - malignant epithelial tumors.
NF1 gene
CA-125
L- myc gene
Chronic inflammatory mediators
34. Neurofibromatosis type 2 22q tumor suppressor (key type 2=22)
Autoimmune (Hashimoto's - myasthenia gravis)
arsenic target
NF2 gene
Leukocyte extravasation: tight binding
35. Neurofibromatosis type 1 17q tumor suppressor
NF1 gene
benign epithelial tumor
arsenic target
Paget's bone disease
36. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
prostate cancer incidence/mortality
intrinsic apoptosis
DCC gene
malignant >1 cell type tumor
37. Mature teratoma in men or malignant teratoma in M/F
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
malignant >1 cell type tumor
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
Napthalene (aniline) dyes target
38. Melanoma - basal cell carcinoma - and especially squamous cell carcinomas of the skin.
Neoplasm associated with xeroderma pigmentosum (albinism)
dysplastic nevus
iron poisoning
vinyl chloride target
39. Tumor marker: (Normal in fetus). Hepatocellular carcinomas. Nonseminomatous germ cell tumors of the testis.
DCC gene
bcl -2 gene
alpha - fetoprotein
S-100
40. Gastric adenocacinoma
cigarette smoke target
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
radiation exposure
Neoplasm associated with Down Syndrome
41. TB - fungal infections - syphilis - leprosy - cat scratch fever - sarcoid - Crohn's - Berylliosis.
granulomatous disease
Chronic inflammatory mediators
CCl4 target
malignant mesenchyme tumor (general)
42. During embryogenesis - hormone induction and atrophy. Increased mitochondrial permeability and cytochrome c release. Increase Bax (pro - apoptotic) - decreased Bcl -2 (anti - apopotic).
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
CA-125
Second - leading cause of death in the US
intrinsic apoptosis
43. Liver (hepatocellular carcinoma)
Autoimmune (Hashimoto's - myasthenia gravis)
nitrosamines (smoked foods) target
blood vessels malignant tumor
aflatoxin target
44. ADH
blood vessels benign tumor
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
abl gene
asbestos target
45. Lung (mesothelioma and bronchogenic carcinoma)
radiation exposure
p53 gene
beta - hCG
asbestos target
46. Liver (angiosarcoma)
fat malignant tumor
Leukocyte extravasation: tight binding
vinyl chloride target
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
47. Most human cancers - specifically Li - Fraumeni syndrome 17p tumor suppressor (blocks G1 to S phase progression)
Barrett's esophagus (chronic GI reflux)
CEA
p53 gene
Acute inflammatory mediators
48. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
radiation exposure
BRCA1 gene
Napthalene (aniline) dyes target
lung cancer incidence/mortality
49. Angiosarcoma
calcitonin
erb - B2 gene
Autoimmune (Hashimoto's - myasthenia gravis)
blood vessels malignant tumor
50. Anaplasia - neoplasia - desmoplasia (fibrous tissue formation in response to neoplasm)
Leukocyte extravasation: rolling
vinyl chloride target
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
Irreversible - plasias